AU3739400A - Flint polypeptide analogs - Google Patents

Flint polypeptide analogs

Info

Publication number: AU3739400A
Authority: AU; Australia
Prior art keywords: polypeptide analogs; flint polypeptide; flint; analogs; polypeptide
Prior art date: 1999-03-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU37394/00A

Inventor

Gerald Wayne Becker

Fredric Jay Cohen

Patricia Ann Gonzalez-Dewhitt

John Edward Hale

Radmila Micanovic

Christy Michelle Newton

Timothy Wayne Noblitt

Radhakrishnan Rathmachalam

Sheng-Hung Rainbow Tschang

Derrick Ryan Witcher

Victor John Wroblewski

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-30

Filing date

2000-03-20

Publication date

2000-10-16

2000-03-20 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2000-10-16 Publication of AU3739400A publication Critical patent/AU3739400A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Biophysics (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU37394/00A 1999-03-30 2000-03-20 Flint polypeptide analogs Abandoned AU3739400A (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
US12683999P	1999-03-30	1999-03-30
US60126839		1999-03-30
US14015699P	1999-06-21	1999-06-21
US14007799P	1999-06-21	1999-06-21
US60140156		1999-06-21
US60140077		1999-06-21
US16056699P	1999-10-20	1999-10-20
US60160566		1999-10-20
US18339800P	2000-02-18	2000-02-18
US60183398		2000-02-18
PCT/US2000/006417 WO2000058465A2 (en)	1999-03-30	2000-03-20	Flint polypeptide analogs

Publications (1)

Publication Number	Publication Date
AU3739400A true AU3739400A (en)	2000-10-16

Family

ID=27537769

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU37394/00A Abandoned AU3739400A (en)	1999-03-30	2000-03-20	Flint polypeptide analogs

Country Status (5)

Country	Link
EP (1)	EP1165780A2 (en)
JP (1)	JP2002539828A (en)
AU (1)	AU3739400A (en)
CA (1)	CA2368760A1 (en)
WO (1)	WO2000058465A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7285267B2 (en)	1997-01-14	2007-10-23	Human Genome Sciences, Inc.	Tumor necrosis factor receptors 6α & 6β
JP2001507937A (en)	1997-01-14	2001-06-19	ヒューマンジノームサイエンシーズ，インコーポレイテッド	Tumor necrosis factor receptor 6α and tumor necrosis factor receptor 6β
PT1015587E (en)	1997-09-18	2008-07-31	Genentech Inc	Dcr3 polypeptide, a tnfr homolog
WO2001018202A2 (en) *	1999-09-10	2001-03-15	Eli Lilly And Company	Flint analog compounds and formulations thereof
WO2001028582A2 (en) *	1999-10-20	2001-04-26	Eli Lilly And Company	Therapeutic applications of flint polypeptides
EP1244783A1 (en) *	1999-12-07	2002-10-02	Eli Lilly And Company	Improving stability of flint through o-linked glycosylation
WO2002060947A2 (en) *	2001-02-01	2002-08-08	Eli Lilly And Company	Glycoforms a fas ligand inhibitory protein analog
AU2002246968A1 (en) *	2001-02-01	2002-08-12	Eli Lilly And Company	Glycoforms a fas ligand inhibitory protein analog
EP1364653A4 (en) *	2001-02-23	2005-01-26	Takeda Pharmaceutical	CASPASE INHIBITORS 3
KR100754667B1 (en)	2005-04-08	2007-09-03	한미약품 주식회사	Immunoglobulin Fc Fragments Modified with Non-Peptide Polymers and Pharmaceutical Compositions Comprising the Same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001507937A (en) *	1997-01-14	2001-06-19	ヒューマンジノームサイエンシーズ，インコーポレイテッド	Tumor necrosis factor receptor 6α and tumor necrosis factor receptor 6β
WO1999004001A1 (en) *	1997-07-21	1999-01-28	Zymogenetics, Inc.	Tumor necrosis factor receptor ztnfr-5
PT1015587E (en) *	1997-09-18	2008-07-31	Genentech Inc	Dcr3 polypeptide, a tnfr homolog
WO2000034782A1 (en) *	1998-12-09	2000-06-15	Eli Lilly And Company	Flint compositions and uses thereof
ES2291197T3 (en) *	1999-03-30	2008-03-01	Eli Lilly And Company	FLINT ANALOGS RESISTANT TO PROTEASES.

2000
- 2000-03-20 WO PCT/US2000/006417 patent/WO2000058465A2/en not_active Ceased
- 2000-03-20 AU AU37394/00A patent/AU3739400A/en not_active Abandoned
- 2000-03-20 EP EP00916263A patent/EP1165780A2/en not_active Withdrawn
- 2000-03-20 CA CA002368760A patent/CA2368760A1/en not_active Abandoned
- 2000-03-20 JP JP2000608746A patent/JP2002539828A/en not_active Withdrawn

Also Published As

Publication number	Publication date
JP2002539828A (en)	2002-11-26
CA2368760A1 (en)	2000-10-05
WO2000058465A2 (en)	2000-10-05
WO2000058465A3 (en)	2001-01-25
EP1165780A2 (en)	2002-01-02

Publication	Publication Date	Title
AU2001284418A1 (en)	2002-06-06	Novel polypeptide
GB9923177D0 (en)	1999-12-01	Novel polypeptide
AU4281999A (en)	1999-12-30	Peptide
AU3739400A (en)	2000-10-16	Flint polypeptide analogs
AU5706000A (en)	2001-01-31	Useful polypeptide
AU4930399A (en)	2000-02-21	Novel Polypeptide
AU2691500A (en)	2000-09-14	Novel polypeptide
GB9923889D0 (en)	1999-12-08	Novel polypeptide
AU4778600A (en)	2000-12-12	Novel polypeptide
GB9924951D0 (en)	1999-12-22	Novel polypeptide
AU6550800A (en)	2001-03-05	Hepoxilin analogs
AU2232399A (en)	1999-08-02	Recombinant ctb-based vaccines
AU1184800A (en)	2000-06-13	Novel polypeptide
AU2109200A (en)	2000-08-07	Polypeptide
GB9923890D0 (en)	1999-12-08	Novel polypeptide
GB9923893D0 (en)	1999-12-08	Novel polypeptide
GB9918680D0 (en)	1999-10-13	Polypeptide
AU1228201A (en)	2001-05-08	Umlr polypeptides
AU6712600A (en)	2001-03-19	Polypeptides
AU6637700A (en)	2001-03-13	Tryptase-like polypeptide ztryp1
AU2002224056A1 (en)	2002-06-03	Novel polypeptide
GB9923888D0 (en)	1999-12-08	Novel polypeptide
GB9924960D0 (en)	1999-12-22	Novel polypeptide
GB9925115D0 (en)	1999-12-22	Novel polypeptide
AUPP704598A0 (en)	1998-12-03	Novel polypeptide

Legal Events

Date	Code	Title	Description
2002-03-07	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase